IL156088A0 - Process for the isolation and purification of epothilones - Google Patents

Process for the isolation and purification of epothilones

Info

Publication number
IL156088A0
IL156088A0 IL15608801A IL15608801A IL156088A0 IL 156088 A0 IL156088 A0 IL 156088A0 IL 15608801 A IL15608801 A IL 15608801A IL 15608801 A IL15608801 A IL 15608801A IL 156088 A0 IL156088 A0 IL 156088A0
Authority
IL
Israel
Prior art keywords
epothilones
isolation
purification
Prior art date
Application number
IL15608801A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL156088A0 publication Critical patent/IL156088A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Silicon Polymers (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15608801A 2000-12-07 2001-12-05 Process for the isolation and purification of epothilones IL156088A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029895.0A GB0029895D0 (en) 2000-12-07 2000-12-07 Organic compounds
PCT/EP2001/014771 WO2002046196A1 (en) 2000-12-07 2001-12-05 Process for the isolation and purification of epothilones

Publications (1)

Publication Number Publication Date
IL156088A0 true IL156088A0 (en) 2003-12-23

Family

ID=9904660

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15608801A IL156088A0 (en) 2000-12-07 2001-12-05 Process for the isolation and purification of epothilones
IL156088A IL156088A (en) 2000-12-07 2003-05-22 Process for isolation and purification of apothilones

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156088A IL156088A (en) 2000-12-07 2003-05-22 Process for isolation and purification of apothilones

Country Status (32)

Country Link
US (2) US6946561B2 (ja)
EP (1) EP1345944B1 (ja)
JP (1) JP4287650B2 (ja)
KR (1) KR100894990B1 (ja)
CN (1) CN1263761C (ja)
AR (1) AR031902A1 (ja)
AT (1) ATE292132T1 (ja)
AU (2) AU2493602A (ja)
BR (1) BR0115991A (ja)
CA (1) CA2433414C (ja)
CZ (1) CZ301664B6 (ja)
DE (1) DE60109814T2 (ja)
DK (1) DK1345944T3 (ja)
EC (1) ECSP034641A (ja)
ES (1) ES2239687T3 (ja)
GB (1) GB0029895D0 (ja)
HK (1) HK1059618A1 (ja)
HU (1) HU224910B1 (ja)
IL (2) IL156088A0 (ja)
MX (1) MXPA03005097A (ja)
MY (1) MY128409A (ja)
NO (1) NO329164B1 (ja)
NZ (1) NZ526197A (ja)
PE (1) PE20020568A1 (ja)
PL (1) PL209406B1 (ja)
PT (1) PT1345944E (ja)
RU (1) RU2285007C2 (ja)
SI (1) SI1345944T1 (ja)
SK (1) SK287356B6 (ja)
TW (1) TWI286137B (ja)
WO (1) WO2002046196A1 (ja)
ZA (1) ZA200304296B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867305B2 (en) 1996-12-03 2005-03-15 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
US6242469B1 (en) 1996-12-03 2001-06-05 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US20020058286A1 (en) * 1999-02-24 2002-05-16 Danishefsky Samuel J. Synthesis of epothilones, intermediates thereto and analogues thereof
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds
US7649006B2 (en) 2002-08-23 2010-01-19 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto and analogues thereof
NZ538522A (en) * 2002-08-23 2008-03-28 Sloan Kettering Inst Cancer Synthesis of epothilones, intermediates thereto, analogues and uses thereof
BRPI0314133A8 (pt) * 2002-09-23 2017-09-19 Bristol Myers Squibb Co Processo para isolamento de epotilona b, métodos para cultivo de microorganismo que produza epotilona a ou b e para purifiação de apotilona
FR2846520B1 (fr) 2002-11-06 2006-09-29 Roquette Freres Utilisation de maltodextrines branchees comme liants de granulation
KR100681811B1 (ko) * 2005-03-15 2007-02-12 성균관대학교산학협력단 생물학적 대사부산물의 효율적인 제거를 통한 유용 이차대사산물의 제조방법
MX2009001635A (es) 2006-08-16 2009-02-23 Novartis Ag Forma de cristal de epotilona b y su uso en composiciones farmaceuticas.
US8906947B2 (en) 2008-02-01 2014-12-09 Zhejiang Hisun Pharmaceutical Co., Ltd. Method for the separation and purification of epothilones
EP2571525A4 (en) 2010-05-18 2016-04-27 Cerulean Pharma Inc Compositions and methods for treating autoimmune and other diseases
KR101372563B1 (ko) * 2011-12-26 2014-03-14 주식회사 삼양바이오팜 에포틸론 함유물질로부터 에포틸론 a와 b의 추출 및 정제 방법
CN110964029B (zh) * 2019-12-19 2020-11-03 鲁南制药集团股份有限公司 一种埃博霉素b发酵液的预处理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138042C2 (de) 1991-11-19 1993-10-14 Biotechnolog Forschung Gmbh Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
DE59712968D1 (de) * 1996-11-18 2008-10-30 Biotechnolog Forschung Gmbh Epothilone E und F
ATE224882T1 (de) * 1997-07-16 2002-10-15 Schering Ag Thiazolderivate, verfahren zur herstellung und verwendung
US6365749B1 (en) * 1997-12-04 2002-04-02 Bristol-Myers Squibb Company Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE19826988A1 (de) * 1998-06-18 1999-12-23 Biotechnolog Forschung Gmbh Epothilon-Nebenkomponenten
ES2332727T3 (es) * 2000-04-28 2010-02-11 Kosan Biosciences, Inc. Epotilona d cristalina.
GB0029895D0 (en) * 2000-12-07 2001-01-24 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
TWI286137B (en) 2007-09-01
ES2239687T3 (es) 2005-10-01
AU2493602A (en) 2002-06-18
CA2433414A1 (en) 2002-06-13
US6946561B2 (en) 2005-09-20
HUP0302579A2 (hu) 2003-11-28
PT1345944E (pt) 2005-08-31
CZ301664B6 (cs) 2010-05-19
EP1345944A1 (en) 2003-09-24
ATE292132T1 (de) 2005-04-15
RU2285007C2 (ru) 2006-10-10
SK6892003A3 (en) 2004-01-08
PE20020568A1 (es) 2002-07-22
CN1479741A (zh) 2004-03-03
ZA200304296B (en) 2004-04-23
NZ526197A (en) 2005-01-28
DE60109814T2 (de) 2006-02-16
AU2002224936B2 (en) 2005-09-22
NO20032591L (no) 2003-06-06
IL156088A (en) 2008-08-07
HU224910B1 (en) 2006-04-28
PL209406B1 (pl) 2011-08-31
US20050288514A1 (en) 2005-12-29
JP4287650B2 (ja) 2009-07-01
KR100894990B1 (ko) 2009-04-24
NO329164B1 (no) 2010-09-06
KR20030053535A (ko) 2003-06-28
CA2433414C (en) 2011-01-25
GB0029895D0 (en) 2001-01-24
EP1345944B1 (en) 2005-03-30
ECSP034641A (es) 2003-07-25
JP2004521879A (ja) 2004-07-22
SK287356B6 (sk) 2010-08-09
AR031902A1 (es) 2003-10-08
MXPA03005097A (es) 2003-09-05
HUP0302579A3 (en) 2004-10-28
CZ20031565A3 (cs) 2003-10-15
WO2002046196A1 (en) 2002-06-13
HK1059618A1 (en) 2004-07-09
NO20032591D0 (no) 2003-06-06
DK1345944T3 (da) 2005-05-30
BR0115991A (pt) 2004-01-13
DE60109814D1 (de) 2005-05-04
SI1345944T1 (sl) 2005-12-31
US20040054188A1 (en) 2004-03-18
MY128409A (en) 2007-01-31
PL361884A1 (en) 2004-10-04
US7569698B2 (en) 2009-08-04
CN1263761C (zh) 2006-07-12

Similar Documents

Publication Publication Date Title
IL222455A0 (en) Methods for the preparation, isolation and purification of epothilone b
HUP0102818A3 (en) Process for purification of citalopram
HUP0102817A3 (en) Process for purification of citalopram
IL156088A0 (en) Process for the isolation and purification of epothilones
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
EP1353933A4 (en) METHOD FOR PURIFYING LACTOSE
PL359560A1 (en) Process for the isolation of lovastatin
IL150019A0 (en) Process for the alleviation of anxiety
GB0011186D0 (en) Modification of bacteria
AU8311901A (en) Polymorphs of zaleplon and methods for the preparation thereof
IL155360A0 (en) Processes for the isolation or purification of plavastatin and compositions containing plavastatin
HUP0301725A3 (en) Novel compounds and process
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
EG22846A (en) Process for the preparation of urea
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
AU2001286489A1 (en) Process for the purification of iosoctane and/or diisobutylene
HU0303170D0 (en) Method for the production of 2-coumarone and substituted 2-coumarones
EG22758A (en) Process for the preparation of urea
GB0012249D0 (en) Process for the preparation of 11-oxaprostaglandins
HRP20000680B1 (en) Process for the preparation of fluconazole
HU0003616D0 (en) Process for the preparation of pyridyl-ketone
GB0028881D0 (en) Process for the preparation of endo-5-norbornene-2-ol
GB0012996D0 (en) Process for the preparation of endo-5-norbornene-2-ol

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed